About REMED
REMED is a company based in Daejeon (South Korea) founded in 2003. The company has 104 employees as of December 31, 2024. REMED offers products and services including Electronic Medicine Solutions and Differentiated Medical Platforms. REMED operates in a competitive market with competitors including Noctrix Health, Neurovalens, Brain in Hand, Zynex and Trexo Robotics, among others.
- Headquarter Daejeon, South Korea
- Employees 104 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Remed Co., Ltd.
-
Annual Revenue
$17.32 M (USD)37.86as on Dec 31, 2024
-
Net Profit
$4.86 M (USD)799.69as on Dec 31, 2024
-
EBITDA
$1.63 M (USD)0as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
104
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of REMED
REMED is a publicly listed company on the KRX with ticker symbol 302550 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of REMED
REMED offers a comprehensive portfolio of products and services, including Electronic Medicine Solutions and Differentiated Medical Platforms.
Tools for non-invasive brain disease treatment and procedures
Platforms supporting psychiatry and veterinary innovations
Funding Insights of REMED
Detailed funding history for REMED
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by REMED
Investment portfolio details for REMED
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - REMED
Detailed financials for REMED
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Remed Comparisons
Peer comparison for REMED
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of REMED
REMED operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Noctrix Health, Neurovalens, Brain in Hand, Zynex and Trexo Robotics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable therapeutic devices for neurological disorders are developed.
|
|
| Locked | Locked | Locked |
A headset-like device for obesity treatment is developed by Neurovalens.
|
|
| Locked | Locked | Locked |
Assistive technology is developed for impaired executive brain functions.
|
|
| Locked | Locked | Locked |
Non-invasive electrotherapy and stroke rehabilitation devices are developed by Zynex.
|
|
| Locked | Locked | Locked |
Battery-operated exoskeletons for children with disabilities are developed.
|
|
| Locked | Locked | Locked |
Medical devices for neurorehabilitation are manufactured for therapy sessions.
|
Detailed competitors of REMED
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Remed
Complete news archive for REMED
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about REMED
REMED was founded in 2003.
REMED is headquartered in Daejeon, South Korea.
As of Dec 31, 2024, the latest employee count at REMED is 104.
Annual revenue of REMED is $17.32M as on Dec 31, 2024.
REMED develops products for the treatment of brain disorders (depression, anxiety, stroke and Parkins), and pain management. Products developed by the company include Transcranial Magnetic Stimulation Therapy device, Electromagnetic Stimulation device, Extracorporeal Shockwave Therapy, Electrosurgical Unit, Patient Monitor, Fetal Monitor, and ECG device.
REMED's top competitors include Neurovalens, Zynex and Noctrix Health.
REMED offers Electronic Medicine Solutions and Differentiated Medical Platforms.
Yes, REMED is publicly traded on KRX under the ticker symbol 302550.
The ticker symbol of REMED is 302550 on KRX.